# name
Neuro-EPO by Nasal Route as a Neuroprotective Therapy in Brain Ischemia

# metadata.dc.description.abstract[].value
Cerebral vascular diseases (CVD) are the third leading cause of death in industrialized
countries and in Cuba affect the 50% of the population above 60 years old. The
mortality is exponentially increased with age and doubles every five years. A total of 22,000
annual cases are estimated in Cuba, a country where life expectance should increase to 80
years in the near future [1].
CVD are often followed by a high social and individual cost as a consequence of disability
and family affectation.
The most problematic among such diseases is ischemic cerebral vascular disease,
characterized by the reduction of cerebral blood flow (CBF) below a critical level. From this
initial event several processes take place to induce the clinical symptoms of cerebral
ischemia...

# metadata.dc.rights[].value
cc by (c) García Rodríguez, Julio César et al., 2012

# metadata.dc.source[].value
Llibres / Capítols de llibre (Biologia Cel·lular, Fisiologia i Immunologia)

# metadata.dc.title[].value
Neuro-EPO by Nasal Route as a Neuroprotective Therapy in Brain Ischemia